Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 115.35%2.69M | ---- | 18.54%-17.53M | ---- | 7.62%-21.52M | ---- | -55.77%-23.29M | ---- | -5,856.97%-14.95M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 33.33%-2K | ---- | 0.00%-3K | ---- | 0.00%-3K | ---- | 0.00%-3K | ---- | 0.00%-3K |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---1.82M | ---- | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | 88.89%13.69M | ---- | 253.39%7.25M | ---- | 1,781.15%2.05M | ---- | 97.00%-122K |
| Impairment and provisions: | ---- | 245.77%207K | ---- | -107.10%-142K | ---- | -80.64%2M | ---- | 596.63%10.33M | ---- | -244.78%-2.08M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 128.88%428K | ---- | 111.34%187K |
| -Impairment of trade receivables (reversal) | ---- | --207K | ---- | ---- | ---- | -90.26%49K | ---- | 118.60%503K | ---- | -187.65%-2.7M |
| -Other impairments and provisions | ---- | ---- | ---- | -107.28%-142K | ---- | -79.24%1.95M | ---- | 2,044.75%9.39M | ---- | --438K |
| Asset sale loss (gain): | ---- | -82,820.00%-4.15M | ---- | ---5K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---4.15M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---5K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -96.30%2K | ---- | -97.69%54K | ---- | -25.90%2.34M | ---- | 3.75%3.16M | ---- | -5.11%3.04M |
| Financial expense | ---- | -35.54%1.27M | ---- | -2.52%1.98M | ---- | 31.39%2.03M | ---- | -34.66%1.54M | ---- | 31.84%2.36M |
| Special items | ---- | -75.35%262K | ---- | -78.24%1.06M | ---- | 9,480.39%4.89M | ---- | -98.85%51K | ---- | -51.94%4.45M |
| Operating profit before the change of operating capital | ---- | 110.57%287K | ---- | 10.07%-2.72M | ---- | 51.04%-3.02M | ---- | 15.59%-6.17M | ---- | -527.58%-7.31M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 76.93%-164K | ---- | -2.45%-711K | ---- | 65.46%-694K | ---- | -89.53%-2.01M | ---- | -186.74%-1.06M |
| Accounts receivable (increase)decrease | ---- | -39.54%-13.09M | ---- | -123.38%-9.38M | ---- | 258.44%40.13M | ---- | -165.53%-25.33M | ---- | 178.03%38.65M |
| Accounts payable increase (decrease) | ---- | -67.26%6.57M | ---- | 156.77%20.05M | ---- | -192.73%-35.32M | ---- | 193.22%38.09M | ---- | -242.97%-40.86M |
| Cash from business operations | ---- | -188.43%-6.41M | ---- | 561.46%7.24M | ---- | -76.13%1.1M | ---- | 143.39%4.59M | ---- | 49.39%-10.57M |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 147.73%84K | ---- | ---176K |
| China income tax paid | ---- | ---- | ---- | ---- | ---- | ---398K | ---- | ---- | ---- | 28.47%-98K |
| Interest paid - operating | ---- | 90.91%-5K | ---- | 54.92%-55K | ---- | 35.45%-122K | ---- | -16.67%-189K | ---- | -52.83%-162K |
| Special items of business | -418.21%-4.41M | ---- | 86.26%-851K | ---- | -273.89%-6.19M | ---- | 509.43%3.56M | ---- | 92.84%-870K | ---- |
| Net cash from operations | -418.21%-4.41M | -189.18%-6.41M | 86.26%-851K | 1,150.09%7.19M | -273.89%-6.19M | -87.17%575K | 509.43%3.56M | 140.72%4.48M | 92.84%-870K | 47.91%-11.01M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -33.33%2K | ---- | 0.00%3K | ---- | 0.00%3K | ---- | 0.00%3K | ---- | 0.00%3K |
| Purchase of fixed assets | ---- | ---- | ---- | 95.85%-8K | ---- | ---193K | ---- | ---- | ---- | -2,600.00%-27K |
| Sale of subsidiaries | ---- | -80.00%1K | ---- | --5K | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | --45K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | ---- | -85.71%1K | ---- | 103.65%7K | ---- | -19,300.00%-192K | ---- | 0.00%1K | ---- |
| Net cash from investment operations | ---- | -93.33%3K | -85.71%1K | 123.68%45K | 103.65%7K | -6,433.33%-190K | -19,300.00%-192K | 112.50%3K | 0.00%1K | -103.69%-24K |
| Net cash before financing | -418.82%-4.41M | -188.58%-6.41M | 86.26%-850K | 1,778.70%7.23M | -283.59%-6.19M | -91.42%385K | 487.80%3.37M | 140.66%4.49M | 92.85%-869K | 46.14%-11.03M |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---- | ---- | ---15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | 2.93%9.78M | ---- | --9.5M | ---- | ---- | ---- | 49.06%20M | ---- | -53.65%13.42M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---21.6M | ---- | ---- |
| Other items of the financing business | ---- | ---- | -100.09%-5K | ---- | 536.45%5.78M | -23.16%906K | -116.02%-1.33M | --1.18M | -35.55%8.27M | ---- |
| Net cash from financing operations | ---- | 232.30%9.24M | -100.09%-5K | -495.40%-6.98M | 536.45%5.78M | 62.64%-1.17M | -116.02%-1.33M | -129.16%-3.14M | -35.55%8.27M | -46.03%10.77M |
| Effect of rate | -764.29%-121K | 17.50%-33K | -100.00%-14K | 75.76%-40K | 41.67%-7K | -16,600.00%-165K | -192.31%-12K | -98.41%1K | 152.00%13K | 373.91%63K |
| Net Cash | -415.79%-4.41M | 1,037.75%2.83M | -111.63%-855K | 131.60%249K | -119.76%-404K | -158.54%-788K | -72.36%2.05M | 604.12%1.35M | 991.45%7.4M | 50.28%-267K |
| Begining period cash | 150.21%4.66M | 12.63%1.86M | 12.63%1.86M | -36.54%1.66M | -36.54%1.66M | 106.82%2.61M | 106.82%2.61M | -13.92%1.26M | -13.92%1.26M | -27.65%1.47M |
| Cash at the end | -86.63%133K | 150.21%4.66M | -20.02%995K | 12.63%1.86M | -73.20%1.24M | -36.54%1.66M | -46.50%4.64M | 106.82%2.61M | 309.54%8.67M | -13.92%1.26M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Changqing (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Changqing (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.